Chief Financial Officer update

Surgical Innovations Group plc

("Surgical Innovations", the "Company", or the "Group")

Chief Financial Officer update

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces that Brent Greetham, Chief Financial Officer ("CFO"), informed the Board yesterday of his intention to step down from his role as CFO and Director of the Board to pursue other interests.

A process to appoint a new CFO is underway and Brent will continue to work with the Group during his six months' notice period to ensure an orderly handover. A further announcement will be made in due course.

In the meantime, David Marsh ("CEO") and the Board and in particular, Andrew Boteler ("Non-Executive Director") a former CFO and Chair of the Company's Audit Committee, will provide additional support to the finance function as required.

David Marsh, CEO of Surgical Innovations, said: "On behalf of the Board we would like to thank Brent for his contribution to the Group and wish him well in his future endeavors. As we look to the year ahead, we remain confident of the opportunities available, of how our  reposable™ technology resonates with the market and the overall prospects of the Group."

For further information please contact:

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs, the Company's Reposable portfolio enables healthcare providers to reduce both plastic waste and their CO2 footprint as they strive for net zero.

Further information

Further details of the Group's businesses and products are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

To receive regular updates by email, please contact [email protected]